Taiwan Semiconductor
TSM
Advanced Micro Devices
AMD
Qualcomm
QCOM
4
Broadcom
AVGO
5
Alibaba
BABA
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 37.950
- +1.530+4.20%
Trading Apr 30 15:48 ET
7.21BMarket Cap-10.66P/E (TTM)
39.540High37.240Low8.64MVolume38.610Open36.420Pre Close330.96MTurnover6.21%Turnover RatioLossP/E (Static)189.88MShares39.54052wk High-4.37P/B5.29BFloat Cap21.62052wk Low--Dividend TTM139.27MShs Float73.500Historical High--Div YieldTTM6.32%Amplitude4.980Historical Low38.299Avg Price1Lot Size
BridgeBio Pharma Key Stats
EPS
According to the latest financial report of BridgeBio Pharma, the latest earnings per share (TTM) for the company is -1.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about BridgeBio Pharma's free cash flow? The latest report shows it as -198.56M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BridgeBio Pharma shows that the company's current ratio is 4.67, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BridgeBio Pharma, the quick ratio is 4.44, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of BridgeBio Pharma? The latest ROE figure is -108.26%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BridgeBio Pharma, the total asset return on investment (ROA) is -33.46%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BridgeBio Pharma's latest financial report to see how their gross margin is doing - currently at 64.57%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BridgeBio Pharma, the net profit margin is -4.55K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025